Clinical trial
Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving Rapid Eye Movement Behavior Disorder with Parkinson's Disease
NCT06710574 is registered in ClinicalTrials.gov with Beijing Friendship Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multimodal Image Technologies Investigate the Role and Mechanism of Probiotics in Improving Rapid Eye Movement Behavior Disorder with Parkinson's Disease
- Lead sponsor
- Beijing Friendship Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- September 1, 2022
- Completion date
- June 30, 2025
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gut microbiomes, magnetic resonance imaging (mri), movement disorders, parkinson disease, probiotic, rapid eye movement sleep behavior disorder